The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Alverdy, John
PropertyValue
overview John Alverdy, MD, has run a continuously funded NIH-funded laboratory that studies the molecular interactions of bacteria and the intestinal mucosa in order to understand how life-threatening infections arise after trauma and major surgery and during critical illness. He has developed several anti-infective polymer-based compounds that can attenuate the virulence of several multi-drug resistant pathogens that cause life threatening infections in surgical patients and works with the IME to synthesize, refine, and scale the compounds for pre-clinical testing. The Alverdy lab seeks to better understand the regulation of virulence expression among potential pathogens through investigating the characteristics of the microbial context, molecular machinery that senses that context, and ultimately the lethal combinations of virulence expression that leads to disease. The majority of our work has focused on the sense and response virulence mechanisms of Pseudomonas aeruginosa, a well characterized and clinically important pathogen. We have shown a remarkable potential for this organisms to respond to host environmental cues related to stress, ischemia, immune activation and nutrient depletion. With this core model of environmental regulation of virulence expression, we are pursuing applications in intestinal transplantation, anastomotic and radiation physiology, necrotizing enterocolitis and ischemia/reperfusion injury. We are also investigating similar sense and response mechanisms in other clinically important organisms, including Staphylococcus aureus and Candida albicans. Finally, we are interested in developing virulence-based therapies to prevent virulence activation through modifications in microenvironment of the stressed host such as phosphate repletion and polymer-mediated mucosal replacement therapies. The ultimate goal of understanding microbial virulence is to provide clinical tools to improve the care of patients. However the complexity of the host-pathogen interaction and the vast amounts of mechanistic information available constitutes a formidable barrier to translational research. Computational agent based modeling is a well suited to dynamically represent mechanistic detail in a modifiable context to recapitulate cellular behavior at the tissue, organ and patient levels.
One or more keywords matched the following items that are connected to Alverdy, John
Item TypeName
Concept Bacteria
Academic Article Effect of immunonutrition on virulence strategies in bacteria.
Academic Article Surgical stress, bacteria, and mucosal immune function.
Academic Article Influence of the critically ill state on host-pathogen interactions within the intestine: gut-derived sepsis redefined.
Academic Article Gut microbial gene expression in mother-fed and formula-fed piglets.
Academic Article Contributions of intestinal bacteria to nutrition and metabolism in the critically ill.
Academic Article Glutamine-supplemented total parenteral nutrition improves gut immune function.
Academic Article Diet creates metabolic niches in the "immature gut" that shape microbial communities.
Academic Article High molecular weight polyethylene glycol (PEG 15-20) maintains mucosal microbial barrier function during intestinal graft preservation.
Academic Article Stochasticity among Antibiotic-Resistance Profiles of Common Burn-Related Pathogens over a Six-Year Period.
Academic Article Ionic Modulation of Bacterial Virulence and Its Role in Surgical Infection.
Academic Article Bacterial colonization and succession in a newly opened hospital.
Academic Article The wound environment, microbial virulence and postoperative infection: Practical lessons for the surgeon.
Academic Article Identification of Collagenolytic Bacteria in Human Samples: Screening Methods and Clinical Implications for Resolving and Preventing Anastomotic Leaks and Wound Complications.
Academic Article Infliximab Does Not Promote the Presence of Collagenolytic Bacteria in a Mouse Model of Colorectal Anastomosis.
Search Criteria
  • Bacteria